CVS Health Net Income 2010-2024 | CVS
CVS Health annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- CVS Health net income for the quarter ending December 31, 2024 was $1.644B, a 19.65% decline year-over-year.
- CVS Health net income for the twelve months ending December 31, 2024 was $4.614B, a 44.7% decline year-over-year.
- CVS Health annual net income for 2024 was $4.614B, a 44.7% decline from 2023.
- CVS Health annual net income for 2023 was $8.344B, a 93.55% increase from 2022.
- CVS Health annual net income for 2022 was $4.311B, a 46.12% decline from 2021.
| CVS Health Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $4,614 |
| 2023 | $8,344 |
| 2022 | $4,311 |
| 2021 | $8,001 |
| 2020 | $7,179 |
| 2019 | $6,634 |
| 2018 | $-594 |
| 2017 | $6,622 |
| 2016 | $5,317 |
| 2015 | $5,237 |
| 2014 | $4,644 |
| 2013 | $4,592 |
| 2012 | $3,864 |
| 2011 | $3,462 |
| 2010 | $3,427 |
| 2009 | $3,696 |
| CVS Health Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,644 |
| 2024-09-30 | $87 |
| 2024-06-30 | $1,770 |
| 2024-03-31 | $1,113 |
| 2023-12-31 | $2,046 |
| 2023-09-30 | $2,261 |
| 2023-06-30 | $1,901 |
| 2023-03-31 | $2,136 |
| 2022-12-31 | $2,334 |
| 2022-09-30 | $-3,406 |
| 2022-06-30 | $3,029 |
| 2022-03-31 | $2,354 |
| 2021-12-31 | $1,397 |
| 2021-09-30 | $1,598 |
| 2021-06-30 | $2,783 |
| 2021-03-31 | $2,223 |
| 2020-12-31 | $973 |
| 2020-09-30 | $1,224 |
| 2020-06-30 | $2,975 |
| 2020-03-31 | $2,007 |
| 2019-12-31 | $1,747 |
| 2019-09-30 | $1,530 |
| 2019-06-30 | $1,936 |
| 2019-03-31 | $1,421 |
| 2018-12-31 | $-419 |
| 2018-09-30 | $1,390 |
| 2018-06-30 | $-2,563 |
| 2018-03-31 | $998 |
| 2017-12-31 | $3,287 |
| 2017-09-30 | $1,285 |
| 2017-06-30 | $1,098 |
| 2017-03-31 | $952 |
| 2016-12-31 | $1,707 |
| 2016-09-30 | $1,540 |
| 2016-06-30 | $924 |
| 2016-03-31 | $1,146 |
| 2015-12-31 | $1,498 |
| 2015-09-30 | $1,246 |
| 2015-06-30 | $1,272 |
| 2015-03-31 | $1,221 |
| 2014-12-31 | $1,321 |
| 2014-09-30 | $948 |
| 2014-06-30 | $1,246 |
| 2014-03-31 | $1,129 |
| 2013-12-31 | $1,265 |
| 2013-09-30 | $1,249 |
| 2013-06-30 | $1,124 |
| 2013-03-31 | $954 |
| 2012-12-31 | $1,116 |
| 2012-09-30 | $1,006 |
| 2012-06-30 | $966 |
| 2012-03-31 | $776 |
| 2011-12-31 | $1,065 |
| 2011-09-30 | $868 |
| 2011-06-30 | $816 |
| 2011-03-31 | $713 |
| 2010-12-31 | $1,026 |
| 2010-09-30 | $809 |
| 2010-06-30 | $821 |
| 2010-03-31 | $771 |
| 2009-12-31 | $1,051 |
| 2009-09-30 | $1,021 |
| 2009-06-30 | $886 |
| 2009-03-31 | $738 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $79.455B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.904B | 28.19 |
| Elevance Health (ELV) | United States | $87.590B | 11.69 |
| Cencora (COR) | United States | $47.362B | 17.19 |
| DiDi Global (DIDIY) | China | $23.670B | 0.00 |
| Natera (NTRA) | United States | $20.908B | 0.00 |
| ICON (ICLR) | Ireland | $16.429B | 14.61 |
| Revvity (RVTY) | United States | $13.985B | 23.45 |
| BioMerieux (BMXMF) | France | $13.758B | 0.00 |
| Viatris (VTRS) | United States | $13.595B | 4.19 |
| Doximity (DOCS) | United States | $13.537B | 70.40 |
| Solventum (SOLV) | United States | $13.178B | 0.00 |
| Avantor (AVTR) | United States | $11.895B | 17.47 |
| CochLear (CHEOY) | Australia | $11.072B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
| HealthEquity (HQY) | United States | $9.484B | 47.58 |
| Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
| Organon (OGN) | United States | $3.884B | 3.96 |
| Sotera Health (SHC) | United States | $3.814B | 20.40 |
| BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
| Surgery Partners (SGRY) | United States | $3.198B | 36.46 |
| Concentras Parent (CON) | United States | $2.951B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
| Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Progyny (PGNY) | United States | $1.961B | 39.71 |
| Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Premier (PINC) | United States | $1.690B | 10.82 |
| Agilon Health (AGL) | United States | $1.500B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
| CareDx (CDNA) | United States | $1.146B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
| Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
| Embecta (EMBC) | United States | $0.798B | 5.47 |
| Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| MultiPlan (MPLN) | United States | $0.472B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| DocGo (DCGO) | United States | $0.453B | 17.08 |
| InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
| Enhabit (EHAB) | United States | $0.406B | 35.09 |
| QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
| Nutex Health (NUTX) | United States | $0.314B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.193B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
| Biodesix (BDSX) | United States | $0.122B | 0.00 |
| So-Young (SY) | China | $0.116B | 19.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
| ModivCare (MODV) | United States | $0.071B | 3.85 |
| Oncology Institute (TOI) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |